These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 32705169

  • 21. A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.
    Laks DR, Oses-Prieto JA, Alvarado AG, Nakashima J, Chand S, Azzam DB, Gholkar AA, Sperry J, Ludwig K, Condro MC, Nazarian S, Cardenas A, Shih MYS, Damoiseaux R, France B, Orozco N, Visnyei K, Crisman TJ, Gao F, Torres JZ, Coppola G, Burlingame AL, Kornblum HI.
    Neuro Oncol; 2018 May 18; 20(6):764-775. PubMed ID: 29136244
    [Abstract] [Full Text] [Related]

  • 22. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 18; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 23. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.
    Zhu G, Liu X, Li H, Yan Y, Hong X, Lin Z.
    Int J Immunopathol Pharmacol; 2018 Nov 18; 32():2058738418814341. PubMed ID: 30477356
    [Abstract] [Full Text] [Related]

  • 24. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells via PI3K/Akt Pathway.
    Su RY, Hsueh SC, Chen CY, Hsu MJ, Lu HF, Peng SF, Chen PY, Lien JC, Chen YL, Chueh FS, Chung JG, Yeh MY, Huang YP.
    Anticancer Res; 2021 Apr 18; 41(4):1859-1870. PubMed ID: 33813391
    [Abstract] [Full Text] [Related]

  • 25. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 18; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 26. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway.
    Zhang MH, Liu J.
    Bioengineered; 2022 Apr 18; 13(4):10047-10060. PubMed ID: 35412944
    [Abstract] [Full Text] [Related]

  • 27. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M.
    Int J Oncol; 2009 Oct 18; 35(4):731-40. PubMed ID: 19724909
    [Abstract] [Full Text] [Related]

  • 28. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
    Zheng L, Yang S, Xu R, Yang Y, Quan J, Lin Z, Quan C.
    Int J Oncol; 2023 Oct 18; 63(4):. PubMed ID: 37594082
    [Abstract] [Full Text] [Related]

  • 29. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
    Li H, Zhao S, Shen L, Wang P, Liu S, Ma Y, Liang Z, Wang G, Lv J, Qiu W.
    Aging (Albany NY); 2021 Apr 21; 13(10):13626-13643. PubMed ID: 34091441
    [Abstract] [Full Text] [Related]

  • 30. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD, Jeevan DS, Tobias M, Murali R, Jhanwar-Uniyal M.
    Oncol Rep; 2013 Oct 21; 30(4):1645-50. PubMed ID: 23877261
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ, Wang Y, Wang YY.
    J Cell Physiol; 2019 Jun 21; 234(6):9577-9591. PubMed ID: 30480801
    [Abstract] [Full Text] [Related]

  • 32. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
    Chen W, Kong KK, Xu XK, Chen C, Li H, Wang FY, Peng XF, Zhang Z, Li P, Li JL, Li FC.
    Int J Oncol; 2018 Feb 21; 52(2):485-495. PubMed ID: 29345288
    [Abstract] [Full Text] [Related]

  • 33. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X, Xia K, Peng S, Tan B, Huang Y, Wang M, He M.
    Dev Neurosci; 2024 Feb 21; 46(3):210-220. PubMed ID: 37757768
    [Abstract] [Full Text] [Related]

  • 34. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR.
    Tutak I, Ozdil B, Uysal A.
    Pathol Res Pract; 2022 Nov 21; 239():154145. PubMed ID: 36240647
    [Abstract] [Full Text] [Related]

  • 35. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
    Neil J, Shannon C, Mohan A, Laurent D, Murali R, Jhanwar-Uniyal M.
    Int J Oncol; 2016 Mar 21; 48(3):1045-52. PubMed ID: 26719046
    [Abstract] [Full Text] [Related]

  • 36. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Wang G, Sun J, Zhao H, Li H.
    Med Sci Monit; 2018 Oct 28; 24():7689-7696. PubMed ID: 30368517
    [Abstract] [Full Text] [Related]

  • 37. Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation.
    Zhu J, Cui G, Chen M, Xu Q, Wang X, Zhou D, Lv S, Fu L, Wang Z, Zuo J.
    J Mol Neurosci; 2013 May 28; 50(1):165-71. PubMed ID: 23011765
    [Abstract] [Full Text] [Related]

  • 38. IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced.
    Zhu H, Zhang Y, Chen J, Qiu J, Huang K, Wu M, Xia C.
    PLoS One; 2017 May 28; 12(1):e0169038. PubMed ID: 28052098
    [Abstract] [Full Text] [Related]

  • 39. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.
    Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA.
    Cancer Res; 2009 May 15; 69(10):4107-11. PubMed ID: 19435890
    [Abstract] [Full Text] [Related]

  • 40. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma.
    Jhanwar-Uniyal M, Gellerson O, Bree J, Das M, Kleinman G, Gandhi CD.
    Adv Biol Regul; 2023 May 15; 88():100946. PubMed ID: 36658088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.